| OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| FROST PHILLIP MD ET AL | CEO & Chairman | Mar 22 | Buy | 1.32 | 200,000 | 264,294 | 200,031,694 | Mar 23 06:52 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Mar 08 | Buy | 1.18 | 1,000,000 | 1,175,384 | 199,831,694 | Mar 09 06:26 AM | | OPKO HEALTH, INC. | 10% Owner | Jan 26 | Buy | 0.35 | 14,285,714 | 5,000,000 | 94,285,714 | Jan 31 08:01 PM | | FROST PHILLIP MD ET AL | CEO & Chairman | Nov 22 | Buy | 1.49 | 300,000 | 446,673 | 198,831,694 | Nov 23 07:10 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Nov 09 | Buy | 1.60 | 200,000 | 319,424 | 198,531,694 | Nov 10 06:56 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Oct 27 | Buy | 1.82 | 100,000 | 182,006 | 198,331,694 | Oct 28 06:49 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Oct 19 | Buy | 1.72 | 100,000 | 172,069 | 198,231,694 | Oct 20 06:24 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Oct 14 | Buy | 1.72 | 100,000 | 171,917 | 198,131,694 | Oct 17 07:14 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Oct 13 | Buy | 1.79 | 100,000 | 179,367 | 198,031,694 | Oct 14 06:57 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Oct 12 | Buy | 1.73 | 100,000 | 172,722 | 197,931,694 | Oct 13 07:43 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Oct 07 | Buy | 1.77 | 75,000 | 132,624 | 197,831,694 | Oct 11 07:47 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Sep 26 | Buy | 1.80 | 50,000 | 89,979 | 197,756,694 | Sep 27 07:29 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Sep 23 | Buy | 1.85 | 50,000 | 92,313 | 197,706,694 | Sep 26 06:59 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Sep 22 | Buy | 1.90 | 50,000 | 94,837 | 197,656,694 | Sep 23 07:20 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Sep 21 | Buy | 1.91 | 50,000 | 95,492 | 197,606,694 | Sep 22 07:39 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Sep 20 | Buy | 1.94 | 50,000 | 96,888 | 197,556,694 | Sep 21 07:23 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Sep 19 | Buy | 1.97 | 50,000 | 98,554 | 197,506,694 | Sep 20 07:20 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Sep 15 | Buy | 2.06 | 200,000 | 412,900 | 197,456,694 | Sep 16 07:42 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Sep 02 | Buy | 2.14 | 100,000 | 214,138 | 197,256,694 | Sep 06 07:50 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Aug 17 | Buy | 2.54 | 200,000 | 507,949 | 197,156,694 | Aug 18 08:22 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Aug 05 | Buy | 2.29 | 350,000 | 802,103 | 196,956,694 | Aug 08 08:05 AM | | Nabel Gary J. | Chief Innovation Officer | Jun 22 | Buy | 2.49 | 240,000 | 597,393 | 19,857,514 | Jun 24 07:52 PM | | FROST PHILLIP MD ET AL | CEO & Chairman | Jun 21 | Buy | 2.39 | 200,000 | 478,857 | 196,606,694 | Jun 22 06:59 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Jun 16 | Buy | 2.31 | 100,000 | 231,327 | 196,406,694 | Jun 17 08:11 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Jun 13 | Buy | 2.36 | 100,000 | 236,498 | 196,306,694 | Jun 14 08:05 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Jun 06 | Buy | 2.79 | 100,000 | 279,227 | 196,206,694 | Jun 07 07:29 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | Jun 01 | Buy | 2.95 | 50,000 | 147,614 | 196,106,694 | Jun 02 08:08 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | May 31 | Buy | 3.02 | 50,000 | 151,177 | 196,056,694 | Jun 01 07:28 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | May 25 | Buy | 2.98 | 50,000 | 148,866 | 196,006,694 | May 26 08:16 AM | | Nabel Gary J. | Chief Innovation Officer | May 18 | Buy | 2.90 | 68,492 | 198,627 | 75,471 | May 19 04:28 PM | | FROST PHILLIP MD ET AL | CEO & Chairman | May 18 | Buy | 2.88 | 50,000 | 143,984 | 195,956,694 | May 19 07:32 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | May 16 | Buy | 2.98 | 150,000 | 446,794 | 195,906,694 | May 17 06:33 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | May 13 | Buy | 3.00 | 200,000 | 599,316 | 195,756,694 | May 16 07:17 AM | | Nabel Gary J. | Chief Innovation Officer | May 12 | Buy | 2.65 | 6,979 | 18,494 | 6,979 | May 19 04:28 PM | | FROST PHILLIP MD ET AL | CEO & Chairman | May 11 | Buy | 2.83 | 400,000 | 1,132,400 | 195,556,694 | May 12 06:50 AM | | FROST PHILLIP MD ET AL | CEO & Chairman | May 10 | Buy | 2.78 | 400,000 | 1,113,560 | 195,156,694 | May 11 06:49 AM | | Zerhouni Elias A. | Vice Chairman and President | May 10 | Buy | 2.79 | 89,600 | 250,396 | 89,600 | May 11 09:01 PM |
|
